Please Wait
Applying Filters...
menu
    • menu
    munit-sa-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Encaleret

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BridgeBio Announces New England Journal of Medicine Publication of Encaleret
    BridgeBio Announces New England Journal of Medicine Publication of Encaleret

    10 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/10/2757352/0/en/BridgeBio-Pharma-Announces-New-England-Journal-of-Medicine-Publication-of-Positive-Encaleret-Proof-of-Concept-Phase-2b-Results-in-Patients-with-Autosomal-Dominant-Hypocalcemia-Type.html

    GLOBENEWSWIRE
    10 Oct 2023
    Share Share
    BridgeBio: +ve PIIb Data, Announces Study Design for PIII Trial of Encaleret
    BridgeBio: +ve PIIb Data, Announces Study Design for PIII Trial of Encaleret

    13 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/13/2461142/0/en/BridgeBio-Pharma-Shares-Positive-Phase-2b-Data-and-Announces-Pivotal-Study-Design-for-Phase-3-Trial-of-Encaleret-in-Autosomal-Dominant-Hypocalcemia-Type-1-ADH1.html

    GLOBENEWSWIRE
    13 Jun 2022
    Share Share
    BridgeBio to Present PIIb Data & Pivotal PIII Study Design of Encaleret in ADH1
    BridgeBio to Present PIIb Data & Pivotal PIII Study Design of Encaleret in ADH1

    09 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/09/2459569/0/en/BridgeBio-Pharma-to-Present-Phase-2b-Data-and-Pivotal-Phase-3-Study-Design-of-Encaleret-in-Autosomal-Dominant-Hypocalcemia-Type-1-ADH1-at-the-Endocrine-Society-ENDO-2022-Annual-Con.html

    GLOBENEWSWIRE
    09 Jun 2022
    Share Share